| Regulatory Notification On Requirement Of Import Authorization For Prioritized List Of Medical Devices. |
| Regulatory Notification On Revised Document Requirement For Medical Devices Registration. |
| Regulatory Notification: Regulation of Drug of Abuse test kits. |
| Regulatory Notification: Cancellation of Marketing Authorization of Orphylline (Theophylline 69 mg+Etophylline 231 mg Tablets). |
| Regulatory Notification on rescheduling of clients visiting time for efficient service delivery. |
| Regulatory Notification on Substandard (contaminated) paediatric medicines identified in WHO region of Africa. |
| Regulatory Notification on Requirement of Technical Authorization for sales, distribution of Medical Devices and Registration of Medical Devices |
| Regulatory Notification for Mandatory Submission of e-dossiers and Sample Submission |
| Regulatory Notification on Requirement of Emergency Use Authorization (EUA) for Import, Sale and Distribution of COVID-19 self-test kits |
| Regulatory Notification on Sale, distribution and use of COVID-19 antigen self-test Kits |
| Regulatory Notification: List of Manufacturers Eligible for Product Registration via Company recognition |
| Regulatory Notification: Introduction of New route of registration for medicine via Company Recognition |
| Regulatory Notification: Amendment of Interim guidelines for regulating face masks (medical grade) to facilitate availability of medical grade face mask in Bhutan |
| Regulatory Notification: Sample exemption acceptance of dossiers in soft copy for the purpose of registration during pandemic |
| Regulatory Notification on Bioequivalence and Biowaiver Requirements for Generic Drugs |
| Regulatory Notification on Sale and Distribution of Health Supplement Products |
| Regulatory Notification on Import of Health Supplements for Personal Use |
| Regulatory Notification on Requirement of Import Authorization for medical syringes |
| Regulatory Notification on Regulation of Medical Masks |
| Regulatory Notification on Emergency Use Authorization procedure and conditions for Deployment of COVID-19 Vaccines |
| Notification DRA/D1/11-NS/20-21/168 Exemption from the requirement o Registration of Chemicals |
| Notification 19/DRA/D4b/12-NTF/19-20/1386 on Hand Sanitizers |
| Notification DRA/DC/Notifications/2019-20/1298 for importing hand sanitizer |
| Notification DRA/D4b/12-NTF/19-20/1207 for personal protective equipment and products |
| Revocation of suspension notification of Ranitidine |
| Regulatory Notification on H.pylori kits |
| Ranitidine - Potential Contamination with N-Nitrosodimethylamine |
| Regulatory Notification on Health Supplement: 19/DRA/DC/Notification/2018-19/117 |
| Regulatory Notification on Health Supplement: 19/DRA/DC/Notification/2018-19/983 |
| Regulatory Notification on Health Supplements: 19/DRA/DC/Notification/2018-19/984 |
| Notification to remind the general public to refrain from purchasing medicines from unauthorized sources |
| Reminder notification on collection of pharmaceutical wastes. |
| Notification on collection of pharmaceutical wastes. |
| Notification on prescribing or dispensing medicines beyond the approved indication |
| Sale and Distribution of Health supplements and Controlled Drugs |
| Regulatory Notification on Fixed Dose Combinations (FDCs) |
| New Procedure for Import Authorization |
| CME Workshop with Competent Persons of Retail Pharmacies, Wholesale & clinics |
| Notification on commencement and acceptance of TTI test kits dossiers for registration |
| Notification on requirement of Orien products for DRA approval |
| Notification on collection of Pharmaceutical waste |
| Public Notification on the use of Oxy-99 |
| Public notification on skin creams and ointments containing steroids |
| Notification on reduction in number of product samples requested during submission of dossiers |
| Notification on the change of Application fee for Product dossier assessment |
| Need for Medical Certification |
| Notification on the change in validity of the authorizations issued by Drug Regulatory Auditory |
| Conditions and requirement for product registration through multinational companies and Expedited Registration Process |
| Notification regarding the sale of Prescription Only Medicines (POM) |
| Notification to the Market Authorization Holders |
| Notification on the changes made in BMRR 2012 |
| Notification For Pharmacy Competency Course |
| Pharmaceutical Waste Notification 09/10/2014 |
